(Q36037507)

11 August 2017

1 reference

title

Molecular pathways in bladder cancer: part 1. (English)

1 reference

11 August 2017

1 reference

Richard T Bryan

1

1 reference

11 August 2017

Syed A Hussain

2

1 reference

11 August 2017

Nicholas D James

3

1 reference

11 August 2017

Janusz A Jankowski

4

1 reference

11 August 2017

D Michael A Wallace

5

1 reference

11 August 2017

publication date

1 March 2005

1 reference

11 August 2017

1 reference

11 August 2017

volume

95

1 reference

11 August 2017

issue

4

1 reference

11 August 2017

page(s)

485-490

1 reference

Delay and survival in bladder cancer

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05325.X

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05325.X

Structure-function studies of ligand-induced epidermal growth factor receptor dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05325.X

Transforming growth factor alpha and epidermal growth factor levels in bladder cancer and their relationship to epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05325.X

Scatter factor is a fibroblast-derived modulator of epithelial cell mobility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05325.X

Hepatocyte growth factor is an invasion/migration factor of rat urothelial carcinoma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05325.X

Fibroblast growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05325.X

Role of integrins in regulating epidermal adhesion, growth and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05325.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05325.X

Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05325.X

Development of anticancer drugs targeting the MAP kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05325.X

Regulation of the G2/M transition by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05325.X

Deletions of the INK4A gene in superficial bladder tumors. Association with recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05325.X

Reduced expression of TGF beta is associated with advanced disease in transitional cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05325.X

Predictive value of expression of transforming growth factor-beta(1) and its receptors in transitional cell carcinoma of the urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05325.X

Apoptosis and its clinical significance for bladder cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05325.X

Insulin-like growth factor II stimulates cell proliferation through the insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05325.X

The IGF axis and programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05325.X

Apoptosis control by death and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05325.X

The effects of malignant transformation on susceptibility of human urothelial cells to CD40-mediated apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05325.X

Cancer. p53, guardian of the genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05325.X

Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05325.X

Mitochondria and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05325.X

bcl-2/bax expression and p53 gene status in human bladder cancer: relationship to early recurrence with intravesical chemotherapy after resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05325.X

Differential expression of bcl-2 family proteins in bladder carcinomas. Relationship with apoptotic rate and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05325.X

Proapoptotic genes BAX and CD40L are predictors of survival in transitional cell carcinoma of the bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05325.X

Bcl-2 expression identifies patients with advanced bladder cancer treated by radiotherapy who benefit from neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05325.X

Telomerase and the maintenance of chromosome ends

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05325.X

Telomerase: its clinical relevance in the diagnosis of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05325.X

Telomerase activity as a potential marker in preneoplastic bladder lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05325.X

10.1111/J.1464-410X.2005.05325.X

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference